AVX 0.00% 2.5¢ avexa limited

potentially important times, page-22

  1. 1,578 Posts.
    lightbulb Created with Sketch. 300
    Factors associated with response to apricitabine in a phase 2b study in treatment-experienced patients with HIV-1 infection
    S. Cox*, J. Southby

    Avexa Ltd, Melbourne, Australia

    All abstracts are under embargo until the date and time of presentation at the conference.

    19-22 July

    http://www.ias2009.org/mainpage.aspx?pageId=334
 
watchlist Created with Sketch. Add AVX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.